




Healthcare News Roundup: Biopharmaceutical
HSMN NewsFeed - 1 Mar 2021
Perrigo Announces Agreement To Sell Generic Rx Business For $1.55 Billion In Total Consideration
Perrigo Announces Agreement To Sell Generic Rx Business For $1.55 Billion In Total Consideration
HSMN NewsFeed - 24 Feb 2021
Clarus Therapeutics Appoints Richard 'Ric' Peterson as Chief Financial Officer
Clarus Therapeutics Appoints Richard 'Ric' Peterson as Chief Financial Officer
HSMN NewsFeed - 18 Feb 2021
OncoSec Appoints Bridget O'Keeffe, Ph.D. as Vice President of Clinical Development
OncoSec Appoints Bridget O'Keeffe, Ph.D. as Vice President of Clinical Development
HSMN NewsFeed - 15 Feb 2021
Avexegen Therapeutics Receives a $2.94M NIH Grant to Advance Treatment for Inflammatory Bowel Disease
Avexegen Therapeutics Receives a $2.94M NIH Grant to Advance Treatment for Inflammatory Bowel Disease
HSMN NewsFeed - 10 Feb 2021
AbbVie and Caribou Biosciences Announce Collaboration and License Agreement for CAR-T Cell Products
AbbVie and Caribou Biosciences Announce Collaboration and License Agreement for CAR-T Cell Products
HSMN NewsFeed - 9 Feb 2021
Lannett Expands Strategic Relationship To Include Biosimilar Fast-Acting Insulin
Lannett Expands Strategic Relationship To Include Biosimilar Fast-Acting Insulin
HSMN NewsFeed - 5 Feb 2021
Jubilant Therapeutics Appoints Dr. Robert Glassman to its Board of Directors
Jubilant Therapeutics Appoints Dr. Robert Glassman to its Board of Directors
HSMN NewsFeed - 2 Feb 2021
Actimed Therapeutics Appoints Frank Misselwitz MD, PhD as Chief Medical Officer
Actimed Therapeutics Appoints Frank Misselwitz MD, PhD as Chief Medical Officer
HSMN NewsFeed - 28 Jan 2021
Lilly and Asahi Kasei Pharma Announce License Agreement for Chronic Pain Drug Candidate
Lilly and Asahi Kasei Pharma Announce License Agreement for Chronic Pain Drug Candidate
HSMN NewsFeed - 19 Jan 2021
Lilly and Merus NV Announce Collaboration to Discover Novel T-Cell Re-Directing Bispecific Antibodies
Lilly and Merus NV Announce Collaboration to Discover Novel T-Cell Re-Directing Bispecific Antibodies
HSMN NewsFeed - 18 Jan 2021
Tessa Therapeutics Receives PRIME Designation from European Medicines Agency for CD30 CAR-T Therapy
Tessa Therapeutics Receives PRIME Designation from European Medicines Agency for CD30 CAR-T Therapy
HSMN NewsFeed - 15 Jan 2021
Lilly Announces $30 Million Limited Partner Investment in Unseen Capital Health Fund
Lilly Announces $30 Million Limited Partner Investment in Unseen Capital Health Fund
HSMN NewsFeed - 13 Jan 2021
EVOQ Therapeutics Announces a License And Collaboration Agreement with Amgen
EVOQ Therapeutics Announces a License And Collaboration Agreement with Amgen
HSMN NewsFeed - 11 Jan 2021
Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs
Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs